Molecular Medicine

Carsten Carlberg graduated in 1989 with a Ph.D. in biochemistry at the Free University Berlin (Germany). After positions as Postdoc at Roche (Basel, Switzerland), Group Leader at the University of Geneva (Switzerland), and Docent at the University of Düsseldorf (Germany), he is since 2000 Full Professor of biochemistry at the University of Eastern Finland in Kuopio (Finland). Since 2022, Prof. Carlberg is ERA Chair for nutrigenomics at the Polish Academy of Science. His work focuses on mechanisms of gene regulation by nuclear hormones, in particular on vitamin D. At present, Prof. Carlberg’s projects focus on epigenome-wide effects of vitamin D on the human immune system in the context of cancer.Eunike Velleuer graduated in 2006 as M.D. at the University of Düsseldorf (Germany) and specialized in 2016 in pediatric hemato-oncology. At present, she serves as Senior Physician at the Helios Children’s Clinic Krefeld as well as Research Associate at the University of Düsseldorf. Her special clinical focus is the cancer predisposition syndrome Fanconi anemia. Herein, her research interest is early detection and prevention of oral squamous cell carcinoma and identifying patients with Fanconi anemia at risk. Furthermore, Dr. Velleuer is interested in increasing patients’ resilience and finding alternative ways for long-lasting empowerment.Ferdinand Molnár received his Ph.D. in Biochemistry from the University of Kuopio (Kuopio, Finland) in 2006. He did his postdoctoral training in Structural Biology at the IGBMC (Illkirch, France). In 2008, he joined the School of Pharmacy at the University of Eastern Finland (Kuopio, Finland) studying the interactions of nuclear receptor with ligands, proteins, and DNA. In 2018, he moved to the Nazarbayev University (Astana, Kazakhstan) where he holds Associate Professor position in the Department of Biology. Prof. Molnár’s interests are integrative structural biology and bioinformatics, eukaryotic transcriptional regulation in health and disease, and recombinant protein production.

• 1. The human genome and its variations.- 2. Gene expression and chromatin.- 3. The basal transcriptional machinery.- 4. Transcription factors and signal transduction.- 5. A key transcription factor family: Nuclear receptors.- 6. DNA methylation.- 7. Histone modifications.- 8. Chromatin remodeling and organization.- 9. Regulatory impact of non-coding RNA.- 10. Genome-wide principles of gene regulation.- 11. Epigenetics in development.- 12. Epigenetics and aging.- 13. Epigenetics and disease.- 14. Cells and tissues of the immune system.- 15. Innate immunity and inflammation.- 16. Adaptive immunity and antigen receptor diversity.- 17. B cell immunity: BCRs, antibodies and their effector functions.- 18. Antigen-presenting cells and MHCs.- 19. T cell immunity: TCRs and their effector functions.- 20. Immunity to bacterial pathogens and the microbiome.- 21. Immunity to viral pathogens and the virome.- 22. Tolerance and transplantation immunology.- 23. Immunological hypersensitivities: Allergy and autoimmunity.- 24. Introduction to cancer.- 25. Oncogenes, signal transduction and the hallmarks of cancer.- 26 Tumor suppressor genes and cell fate control.- 27. Multistep tumorigenesis and genome instability.- 28. Cancer genomics.- 29. Cancer epigenomics.-30. Aging and cancer.- 31. Tumor microenvironment.- 32 Metastasis and cachexia.- 33. Cancer immunology.- 34 Architecture of cancer therapies.- 35 Nutrition and common diseases.- 36 Interference of the human genome with nutrients.- 37. Nutritional epigenetics, signaling and aging.- 38. Chronic inflammation and metabolic stress.- 39. Obesity.- 40. Insulin resistance and diabetes.- 41. Heart disease and the metabolic syndrome.- 42 Epigenetics, inflammation and disease.